申请人:BRISTOL-MYERS SQUIBB COMPANY
公开号:US20190282714A1
公开(公告)日:2019-09-19
The present invention relates to radiolabeled IDO1 inhibitors or pharmaceutically acceptable salts thereof which are useful for the quantitative imaging of IDO enzymes in mammals.